• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Lawrence Rosen, MD

Creating a new health care paradigm FOR THE WHOLE CHILD

  • Home
  • About
    • About Dr. Rosen
    • About the Practice
    • About the Book
    • About the Movement
  • Press
  • Stories

Current Affairs, Therapies · October 11, 2007

Cold Med Recall

Related to my post earlier this month, the Consumer Healthcare Products Association released a statement today announcing a voluntary recall of infant cold medications.  The American Academy of Pediatrics press release about the recall follows.

Cough and Cold Medicines for Infants and Children Withdrawn

 

The AAP applauds the decision of pharmaceutical companies
to withdraw cough and cold medicines for infants and children under 2
years of age. Evidence from controlled trials show that these products
are not effective in children under 6 and can have potentially serious
side effects. Dosage guidelines for cold and cold mixtures are
extrapolated from adult data and thus inaccurate for children.
According to the Consumer Healthcare Products Association (CHPA), the
cough and cold medicines that are being withdrawn are:

  • Dimetapp(R) Decongestant Plus Cough Infant Drops,
  • Dimetapp(R) Decongestant Infant Drops,
  • Little Colds(R) Decongestant Plus Cough,
  • Little Colds(R) Multi-Symptom Cold Formula,
  • PEDIACARE(R) Infant Drops Decongestant (containing pseudoephedrine),
  • PEDIACARE(R) Infant Drops Decongestant & Cough (containing pseudoephedrine),
  • PEDIACARE(R) Infant Dropper Decongestant (containing phenylephrine),
  • PEDIACARE(R) Infant Dropper Long-Acting Cough,
  • PEDIACARE(R) Infant Dropper Decongestant & Cough (containing phenylephrine),
  • Robitussin(R) Infant Cough DM Drops,
  • Triaminic(R) Infant & Toddler Thin Strips(R) Decongestant,
  • Triaminic(R) Infant & Toddler Thin Strips(R) Decongestant Plus Cough,
  • TYLENOL(R) Concentrated Infants’ Drops Plus Cold,
  • TYLENOL(R) Concentrated Infants’ Drops Plus Cold & Cough.

    Treatment of colds/upper respiratory infection should include
    plenty of fluids, rest, use of a bulb syringe to clear nasal passages,
    and in some instances saline nose drops.

    The AAP will be participating in the October 18-19, 2007 joint
    meeting of the FDA Non-prescription Drugs advisory Committee and the
    Pediatric Advisory Committee at which time FDA will discuss the safety
    and efficacy of over-the-counter cough and cold products marketed for
    pediatric use.

  • facebookShare on Facebook
    TwitterTweet
    FollowFollow us

    Filed Under: Current Affairs, Therapies

    Previous Post: « Sports Drinks Gone Wild
    Next Post: Abraham Cherrix update »

    Reader Interactions

    Leave a Reply Cancel reply

    You must be logged in to post a comment.

    Primary Sidebar

    Browse Stories by Category

    Latest Stories

    • Resilience
    • What is Whole Health?
    • Whole Health Learning: The Revolutionary Child of Integrative Health and Education
    • Earth Day: Talking with Children about Climate Change
    • Rx Life: The integrative solution to keep kids healthy
    • Greening Healthcare: Next Steps
    • The Growing Pediatric Health Gap: Environmental Injustice Threatens Our Future
    • 13 Inspirational Quotes From Your Favorite Children’s Books
    • Antibiotic Overuse: A Worldwide Emergency
    • School Stress: Rescuing Our Children

    Subscribe to Our Stories


     

    Footer

    Contact

    Lawrence D. Rosen, MD
  • contact@lawrencerosenMD.com
  • 201-634-1600
  • Browse Stories by Category

    Stay Connected

    • Facebook
    • Instagram
    • YouTube

    Copyright © 2025 · Lawrence Rosen, MD · Developed by Renaissance Web Solutions

    • Home
    • About
      • About Dr. Rosen
      • About the Practice
      • About the Book
      • About the Movement
      • Back
    • Press
    • Stories